|
introduction
| abstracts and presentations | venue | speakers
| delegate
list
| supporters | sponsors
|
evaluation
Abstracts
and presentations
| Key: |
|
|
|
|
 |
= View powerpoint presentation online |
 |
= Listen to speech online |
 |
= Download presentation text |
| |
|
|
|
|
|
Speakers listed
alphabetically:
A
|
B
|
C |
D
| E
| F
| G
| H
| I
| J
| K
| L
| M
| N
| O
| P
| Q
| R
| S
| T
| U
| V
| W
| X
| Y
| Z
Full
audio online for the following presentations:
| Dr Peter Cohen : |
Should
we continue to socially construct cocaine and amphetamine use as
deviance or pathology? |
| Matt
Cope
: |
Speeding
on top of my script, how it felt and why it was harm reduction |
| Julia Cottier : |
Setting
up a 'no waiting-list' service - the Wirral experience |
| Paul
Hayes : |
Debate
(for the motion) "This house believes that we need more coercive
testing and treatment services" |
| Dr Robert Newman : |
Scaling
up treatment: Anyone can do it! Lessons from around the world |
| Ron
Peponis : |
Models
of involvement: lessons from the mental health field |
| Dr
Judith Rumgay : |
Debate
(against the motion) "This house believes that we need more
coercive testing and treatment services" |
| Dr
Sharon Stancliff
: |
A
harm reduction approach to poly-substance use by people in methadone
treatment (a report on best practice in the prohibition obsessed
USA) |
| Paul
Wells : |
Debate
(against the motion) "This house believes that we need more
coercive testing and treatment services" |
| Peter
Wheelhouse : |
Debate
(for the motion) "This house believes that we need more coercive
testing and treatment services" |
TOP
Speakers listed
alphabetically:
A
|
B
|
C |
D
| E
| F
| G
| H
| I
| J
| K
| L
| M
| N
| O
| P
| Q
| R
| S
| T
| U
| V
| W
| X
| Y
| Z
Martin
Bennett
Pharmacist, Managing Director and Chair of Associated Chemists
(Wicker) Ltd
Supervised
consumption with dignity: an impossibility? and Working with drug users:
dangers, risks, myths and reality
Abstract
|
Biography
|
Powerpoint
Susan
Bennett
Consultant,
LCS Ltd
What's
happening in the drugs field?
Abstract
|
Biography
|
Powerpoint
Rachel
Britton
Pharmacy Practice,
University of Bath
Supervised
consumption with dignity: an impossibility? and Working with drug users:
dangers, risks, myths and reality
Abstract
|
Biography
|
Powerpoint
Derek
Bunce
Research
Fellow, Regional Research Institute, University of Wolverhampton
User
involvement in the West Midlands: First year results from a three year
study
Abstract
| Powerpoint
TOP
Dr
Peter Cohen
Associate
Professor and Director of the Centre for Drug Research, University of
Amsterdam
Should
we continue to socially construct cocaine and amphetamine use as deviance
or pathology?
Abstract
|
Biography
|
Listen
to speech
Matt
Cope
Contracts
Manager, Southend DAT
Speeding
on top of my script, how it felt and why it was harm reduction
Abstract
|
Biography
| Full
text of presentation Listen
to speech 
Dr
Jan Copeland
Senior
Lecturer, National Drug and Alcohol Research Centre, School of Community
Medicine and Public Health University of New South Wales
Australian
Adolescent Cannabis Check-up
Abstract
Dr
Alex Copello
Consultant
Psychologist and Clinical Director, Birmingham & Solihull Substance
Misuse Services
Are
all talking therapies the same?
Biography
|
Powerpoint
Julia
Cottier
Clinical
Services Manager, Chester & Ellesmere Port Drug Services
Setting
up a 'no waiting-list' service - the Wirral experience
Abstract
|
Biography
|
Powerpoint
Listen
to speech
TOP
Bob
Dunkley
Community
Pharmacist, Dewsbury, West Yorkshire
Crushing
buprenorphine and supervised consumption
Abstract
|
Biography
|
Powerpoint
TOP
Rhoda
Emlyn-Jones
Service
Manager, Social Services, Cardiff and the Vale Local Authorities
Setting
up an effective child and family service
Abstract
|
Biography
|
Powerpoint
TOP
Dr
Emily Finch
Clinical
Team Leader, NTA
Managing
mild to moderate mental health problems
Abstract
|
Biography
|
Powerpoint
Dr
Chris Ford
Chair,
The Alliance
Working
with crack, benzo and alcohol use in primary care
Abstract
|
Biography
|
Powerpoint
Jaye
Foster
Healthy
Options Team, East London and The City Mental Health NHS Trust
Two
case studies of service user involvement in the recruitment of staff
for drug services
Abstract
|
Powerpoint
Diane
French
Standards
and Inspection Manager, National Treatment Agency
Joint
reviews of substance misuse
Abstract
|
Powerpoint
TOP
Daren
Garratt
Development
Manager, The Alliance
DAT
funded and facilitated user involvement
Abstract
|
Biography
|
Powerpoint
TOP
Christopher
Hallam
Freelance writer
and researcher
Gum
fatale: how opium began its deviant career
Abstract
|
Biography
|
Powerpoint
Paul
Hayes
Chief
Executive, National Treatment Agency
Debate:
" This house believes that we need more coercive testing and treatment
services"
Biography
|
Listen
to speech
Neil
Hunt
Director
of Research, KCA
Two
case studies of service user involvement in the recruitment of staff
for drug services
Abstract
|
Powerpoint
TOP
Alan
Joyce
Senior
Advocate Worker, The Alliance
'Geriaddicts': aging and dependence
Abstract
|
Biography
TOP
Dr
Michael Kelleher
Consultant
Psychiatrist, Maudsley Hospital, London
Responding
to crack cocaine use in a drug treatment setting
Abstract
|
Biography
Rob
Kenyon
Workforce
Development & Clinical Governance Advisor, Centre for Research in
Primary Care, Nuffield Institute for Health
Are
all talking therapies the same?
Biography
|
Powerpoint
TOP
Noreen
Langan
Chief
Executive, Burton Addiction Centre
Residential
rehab: does staying the night make any difference?
Abstract
|
Biography
Mike
Linnell
Director
of Communications, Lifeline Drugs Project
'Mad
dogs and Englishmen': Lifeline's roasting at the hands of the media
Abstract
|
Biography
TOP
Monica
McCusker
Research
Coordinator, MBST Substance Misuse Service
Involving
service users in research and development
Abstract
|
Powerpoint
Evaluation of an inpatient detoxification unit (Kenyon House) for drugs
and alcohol
Abstract
Evaluation
of a pilot project of direct admission to Tier 4 services (a
poster presentation)
Abstract
|
Powerpoint
Karen
McElrath
Reader,
School of Sociology and Social Policy, Queen's University, Belfast
Injecting,
drug treatment and needle exchange in Northern Ireland
Abstract
|
Biography
|
Powerpoint
Tim
McSweeney
Research
Fellow, Institute for Criminal Policy Research, School of Law, King's
College London
DTTOs
England vs. Scotland: an 'international comparison'
Abstract
|
Biography
|
Powerpoint
Lou
Mousley
Team
Leader, Leics Community Drug Team
An introduction to the Stars National Initiative
Abstract
|
Powerpoint
TOP
Professor
Joanne Neale
Honorary
Senior Research Fellow, Centre for Drug Misuse Research, University
of Glasgow
Comparing
community and prison-based drug treatments
Abstract
|
Biography
|
Powerpoint
Dr
Robert Newman
Director
of the Baron Edmond de Rothschild Chemical Dependency Institute, Beth
Israel Medical Centre, New York, USA Scaling
up treatment: Anyone can do it! Lessons from around the world
Abstract
|
Biography
|
Powerpoint
Listen
to speech
TOP
Richard
Pates
Consultant
Clinical Psychologist, Community Addictions Unit, Cardiff
Amphetamines:
use, problems and responses
Abstract
|
Biography
|
Powerpoint
Ron
Peponis
Philosopher
and Expert by Experience, NIMHE.
Models
of involvement: lessons from the mental health field
Powerpoint
Listen
to speech
Beryl
Poole
The Alliance
'Geriaddicts': aging and dependence
Abstract
|
Biography
William
Pryor
Writer,
publisher and film producer
Unhooked:
mysticism and addiction
Abstract
|
Biography
|
Powerpoint
TOP
Alan
Rosenbach
Head,
Sussex DAAT
Workforce
strategy
Abstract
|
Biography
|
Powerpoint
Dr
Judith Rumgay
Senior
Lecturer in Social Policy, London School of Economics
Debate:
" This house believes that we need more coercive testing and treatment
services"
Biography
|
Full
text of presentation 
Listen
to speech
TOP
Simon
Shepherd
Chief
Executive of the Federation of Drug and Alcohol Professionals
The '2 year rule': employment of current and former drug users
Abstract
|
Biography
Dr
Sharon Stancliff
Medical
Director of the Harm Reduction Coalition, New York, USA
A harm reduction approach to poly-substance use by people in methadone
treatment (a report on best practice in the prohibition obsessed USA)
Abstract
|
Biography
|
Powerpoint
Listen
to speech
Professor
Gerry Stimson
Chief
Executive, The International Harm Reduction Association
Harm reduction and drug treatment: a global perspective
Abstract
|
Biography
Professor
John Strang
Director
of the National Addiction Centre, Institute of Psychiatry, King’s
College London
Injectables
a year on: first indications from the pilots
Abstract
|
Biography
TOP
Richard
Tamlyn
Head
of Consultancy, DrugScope
How
to commission successful consultancy
Abstract
|
Biography
|
Powerpoint
TOP
Ian
Wardle
Chief
Executive, Lifeline
The state of drug treatment in the UK
Abstract
|
Biography
|
Powerpoint
Kerry
Webb
Clinical
Nurse Specialist in Addiction Psychiatry, Liver Unit, Queen Elizabeth
Hospital, Birmingham
Should
we drink with drugs?
Abstract
|
Biography
|
Powerpoint
Paul
Wells
Health
Inclusion Manager, Coventry CDT
Debate:
" This house believes that we need more coercive testing and treatment
services"
Biography
|
Listen
to speech
Peter
Wheelhouse
Head,
Criminal Justice Interventions Programme (CJIP), Drugs Strategy Directorate,
Home Office
Debate:
" This house believes that we need more coercive testing and treatment
services"
Biography
|
Listen
to speech
John
Witton
Health
Services Research Co-ordinator, National Addiction Centre
New treatments and frameworks for evaluating them
Abstract
|
Biography
|
Powerpoint
TOP
Rowdy
Yates
Senior Research Fellow, Scottish Addiction Studies, Sociology,
Social Policy and Criminology Section, University of Stirlin
DTTOs
England vs. Scotland: an 'international comparison'
Abstract
| Biography
| Powerpoint
An evaluation of the Scottish Drug Courts
Abstract
|
Biography
|
Powerpoint
Dr
David Young
Clinical
Director of the Drug and Alcohol Directorate, East and Central Cheshire,
Cheshire and Wirral Partnership Trust
Treating
the person rather than the drugs
Abstract
|
Biography
|
Powerpoint
TOP
Programme
*
- denotes change and/or addition to printed programme
|
Day
1 - Programme
Monday
21st February 2005
Chair: Dr
Chris Ford, Chair of The Alliance |
| |
|
Setting
the scene
Plenary
session |
|
09.45 |
|
Welcome
and introduction |
|
10.00 |
|
Harm
reduction and drug treatment: a global perspective
Professor
Gerry Stimson, Chief Executive, The International Harm Reduction
Association |
|
10.30 |
|
The
state of drug treatment in the UK
Ian Wardle, Chief Executive, Lifeline |
|
11.00 |
|
Coffee |
|
|
|
User
involvement: the way forward
Plenary session |
|
11.30 |
|
Models
of involvement: lessons from the mental health field
*
Ron
Peponis, Philosopher and Expert by Experience, NIMHE.
(Please note change of speaker as Ron replaces Reg McKenna) |
|
12.00 |
|
What's
happening in the drugs field?
Susan Bennett, Consultant, LCS Ltd |
|
12.30 |
|
DAT
funded and facilitated user involvement
Daren Garratt, Development Manager, The Alliance
|
|
1.00 |
|
Lunch |
|
2.30 |
|
Parallel
sessions
Main
Hall
Injectables
a year on: first indications from the pilots
*
Professor
John Strang, Director of the National Addiction Centre, Institute
of Psychiatry, King’s College London
Break-out rooms
Setting
up an effective child and family service
Rhoda Emlyn-Jones, Service Manager, Social Services, Cardiff
and the Vale Local Authorities
Managing
mild to moderate mental health problems
Dr Emily Finch, Clinical Team Leader, NTA
Should
we drink with drugs?
Kerry Webb, Clinical Nurse Specialist in Addiction Psychiatry,
Liver Unit, Queen Elizabeth Hospital, Birmingham
Workforce
strategy
Alan Rosenbach, Head, Sussex DAAT
Amphetamines:
use, problems and responses
Richard Pates, Consultant Clinical Psychologist, Community
Addictions Unit, Cardiff
Gum
fatale: how opium began its deviant career
Christopher Hallam, freelance writer and researcher
DTTOs
England vs. Scotland: an 'international comparison'
*
Chaired
by: Susanne MacGregor, Professor of Social Policy,
Department of Public Health and Policy, London School of Hygiene
and Tropical Medicine.
Tim McSweeney, Research Fellow, Institute for Criminal
Policy Research, School of Law, King's College London and
Rowdy Yates, Senior Research Fellow, Scottish Addiction
Studies, Sociology, Social Policy and Criminology Section, University
of Stirling
Injecting,
drug treatment and needle exchange in Northern Ireland
Karen McElrath, Reader, School of Sociology and Social
Policy, Queen's University, Belfast
Service
user involvement *
Presentations chaired by Danny Morris, UKHRA:
1. Involving
service users in research and development
Tony Pickup, Billy Tompkins & Monica McCusker, Research
Coordinator, MBST Substance Misuse Service
2. Two
case studies of service user involvement in the recruitment of
staff for drug services
Jaye Foster, Karen Tyrell, Vanessa Cropper & Neil Hunt
3. User
involvement in the West Midlands: First year results from a three
year study
Derek Bunce, Research Fellow, Regional Research Institute,
University of Wolverhampton |
|
3.45 |
|
Coffee |
|
4.15 |
|
Debate
Plenary session
Motion: "This
house believes that we need more coercive testing and treatment
services" * |
|
|
|
| Proposing: |
Peter
Wheelhouse, Head, Criminal Justice Interventions Programme
(CJIP), Drugs Strategy Directorate, Home Office |
| Seconding: |
Paul
Hayes, Chief Executive, National Treatment Agency |
| Opposing: |
Paul
Wells, Health Inclusion Manager, Coventry CDT |
| Seconding: |
Dr
Judith Rumgay, Senior Lecturer in Social Policy, London
School of Economics |
|
|
5.00 |
|
Close |
|
5.00 |
|
5.00 - 7.00
Drinks reception and buffet |
|
5.00 |
|
Alliance open meeting |
|
5.30 |
|
Evening
fringe meetings
Main
Hall
Unhooked:
mysticism and addiction *
William Pryor, writer, publisher and film producer
Break-out
rooms
'Mad
dogs and Englishmen': Lifeline's roasting at the hands of the
media
Mike Linnell, Director of Communications, Lifeline Drugs
Project
How
to commission successful consultancy
Richard Tamlyn, Head of Consultancy, DrugScope
Martindale
drinks reception *
Schering-Plough
meeting *
Pharmacy
issues - a special interest meeting sponsored by Boots
Chairs: Rachel Britton, Pharmacy Practice, University of
Bath and
Martin Bennett, Pharmacist, Managing Director and Chair
of Associated Chemists (Wicker) Ltd
Presentations:
Working
with drug users: dangers, risks, myths and reality
Supervised
consumption with dignity: an impossibility? |
TOP
|
Day
2 - Programme
Tuesday
22nd February 2005
Chair: Bill
Nelles |
| |
|
Using
on top: the impact of non-opioid drug use on opiate maintenance
treatment
Plenary session |
|
09.45 |
|
A
harm reduction approach to poly-substance use by people in methadone
treatment
(a report on best practice in the prohibition obsessed USA)
*
Dr Sharon Stancliff, Medical Director of the Harm Reduction
Coalition, New York, USA |
|
10.10 |
|
Responding
to crack cocaine use in a drug treatment setting
Dr Michael Kelleher, Consultant Psychiatrist, Maudsley Hospital,
London |
|
10.30 |
|
Working
with crack, benzo and alcohol use in primary care
Dr Chris Ford, Chair, The Alliance |
|
10.45
|
|
Speeding
on top of my script, how it felt and why it was harm reduction
Matt Cope, Contracts Manager, Southend DAT |
|
11.00 |
|
Panel and questions |
|
11.15 |
|
Coffee |
|
|
|
Parallel
sessions
Main
hall
Should
we continue to socially construct cocaine and amphetamine use
as deviance or pathology?
Dr Peter Cohen, Associate Professor and Director of the
Centre for Drug Research, University of Amsterdam
Break-out rooms
Are
all talking therapies the same?
*
Chair: Mike Ashton, Editor, Findings Drugs and Alcohol
Magazine
Rob Kenyon, Workforce Development & Clinical Governance
Advisor, Centre for Research in Primary Care, Nuffield Institute
for Health.
Dr
Alex Copello
Consultant Psychologist and Clinical Director, Birmingham &
Solihull Substance Misuse Services
Comparing
community and prison-based drug treatments
*
Professor Joanne Neale, Honorary Senior Research Fellow,
Centre for Drug Misuse Research, University of Glasgow
The
'2 year rule': employment of current and former drug users
Simon Shepherd, Chief Executive of the Federation of Drug
and Alcohol Professionals
Crushing
buprenorphine and supervised consumption
Bob Dunkley, Community Pharmacist, Dewsbury, West Yorkshire
Treating
the person rather than the drugs
Dr David Young, Clinical Director of the Drug and Alcohol
Directorate, East and Central Cheshire, Cheshire and Wirral Partnership
Trust
Residential
rehab: does staying the night make any difference?
Noreen Langan, Chief Executive, Burton Addiction Centre
'Geriaddicts':
aging and dependence
Alan Joyce, Senior Advocate Worker, The Alliance and Beryl
Poole, The Alliance
New
treatments and frameworks for evaluating them
John Witton, Health Services Research Co-ordinator, National
Addiction Centre
Young
people & In patient detoxification *
Chaired by Kim Clarke, Clinical Governance and Research
Co-ordinator, Addictions Division, Specialist Services Directorate
Presentations:
1. Australian
Adolescent Cannabis Check-up
Dr Jan Copeland, Senior Lecturer, National Drug and Alcohol
Research Centre, School of Community Medicine and Public Health
University of New South Wales
2. An
introduction to the Stars National Initiative
Lou Mousley, Team Leader, Leics Community Drug Team
3. Evaluation
of an inpatient detoxification unit (Kenyon House) for drugs and
alcohol
Monica McCusker, Research Coordinator, MBST Substance Misuse
Service
Scottish
Drug Courts & Joint Reviews of Substance Misuse
*
Paper
presentations session chaired by Des Flannagan:
An
evaluation of the Scottish Drug Courts
Rowdy Yates, Senior Research Fellow, Scottish Addiction Studies,
Sociology, Social Policy and Criminology Section, University of
Stirling
Joint
reviews of substance misuse
Diane French, Standards and Inspection Manager, National
Treatment Agency |
|
1.00 |
|
Lunch |
|
|
|
Providing
quality treatment: building capacity and providing quality treatment
Plenary session |
|
2.00 |
|
Setting
up a 'no waiting-list' service - the Wirral experience
Julia Cottier, Clinical Services Manager, Chester &
Ellesmere Port Drug Services
|
|
2.40 |
|
Scaling
up treatment: Anyone can do it! Lessons from around the world
Dr Robert Newman, Director of the Baron Edmond de Rothschild
Chemical Dependency Institute, Beth Israel Medical Centre, New
York, USA |
|
|
|
Summing up
and close |
|
3.30 |
|
Coffee |
*
- denotes change and/or addition to printed programme
Download
full conference flyer as pdf 
Flyer format
is PDF (380KB) and requires Adobe Acrobat Reader to be installed
on your computer. If your computer does not have Acrobat Reader
installed click
here to download the free software from the Adobe website.
|
TOP
| INTRODUCTION
|
